We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BBIO market cap is 4.92B. The company's latest EPS is USD -3.6581 and P/E is -7.63.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 338k | 1.87M | 1.83M | 1.64M | 4.09M |
| Operating Income | -129.12M | -129.23M | -126.16M | -146.1M | -157.69M |
| Net Income | -137.34M | -137.59M | -140.16M | -157.9M | -177M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 40.56M | 8.25M | 69.72M | 77.65M | 9.3M |
| Operating Income | -287.11M | -474.48M | -546.72M | -512.2M | -607.37M |
| Net Income | -260.59M | -448.72M | -562.54M | -481.18M | -643.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 728.74M | 623.04M | 625.68M | 503.66M | 655.01M |
| Total Liabilities | 1.86B | 1.87B | 1.84B | 1.85B | 1.85B |
| Total Equity | -1.13B | -1.24B | -1.21B | -1.35B | -1.2B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 631.68M | 703.59M | 1.01B | 623.04M | 546.38M |
| Total Liabilities | 155.7M | 595.7M | 1.88B | 1.87B | 1.89B |
| Total Equity | 473.73M | 106.26M | -867M | -1.24B | -1.34B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -326.25M | -419.49M | -144.32M | -257.68M | -402.9M |
| Investing | 435.18M | 453.15M | 12.3M | 16.42M | 54.1M |
| Financing | -19.51M | -13.13M | 150.25M | 149.02M | 456.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -253.59M | -399.71M | -497.93M | -419.49M | -527.72M |
| Investing | -217.25M | -52.99M | -200.83M | 453.15M | 54.03M |
| Financing | 398.79M | 447.19M | 736.45M | -13.13M | 451.54M |
| Market Cap | 4.92B |
| Price to Earnings Ratio | -7.63 |
| Price to Sales Ratio | 527.79 |
| Price to Cash Ratio | 13.06 |
| Price to Book Ratio | -3.66 |
| Dividend Yield | - |
| Shares Outstanding | 175.83M |
| Average Volume (1 week) | 1.58M |
| Average Volume (1 Month) | 1.6M |
| 52 Week Change | 97.60% |
| 52 Week High | 44.32 |
| 52 Week Low | 12.75 |
| Spread (Intraday) | 0.01 (0.04%) |
| Company Name | BridgeBio Pharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bridgebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
